The latest closing stock price for Aptevo Therapeutics as of March 28, 2025 is 1.12.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -73.64% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 182335.98 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 180.37, which is 16004.5% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 1.12, which is 0% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 16.06.
An investor who bought $1,000 worth of Aptevo Therapeutics stock at the IPO in 2016 would have $-1,000 today, roughly -1 times their original investment - a -73.64% compound annual growth rate over 9 years.
The all-time high Aptevo Therapeutics stock closing price was 182335.98 on July 20, 2016.
The Aptevo Therapeutics 52-week high stock price is 180.37, which is 16004.5% above the current share price.
The Aptevo Therapeutics 52-week low stock price is 1.12, which is 0% below the current share price.
The average Aptevo Therapeutics stock price for the last 52 weeks is 16.06.